SBRT as a Salvage Option for Localized Recurrent Prostate Cancer
Donald B. Fuller, M.D. has been practicing medicine since 1988. He enjoys maximizing the power of technology against cancer by staying at the leading edge of technology innovation, and believes in putting new treatments into practice as soon as they become available.
From TBI to TMI for Advanced Onco-Hematological Diseases
Radiation Oncology Department, IRCCS Policlinico San Martino, Genova, Italy
Re-irradiation with SBRT for Pancreatic Cancer
Professor and Chairman of Radiation Oncology Department, Chairman of CyberKnife Center, Changhai Hospital, China
Prof. Zhang specializes in malignant tumor (pancreatic tumor, primary liver cancer, liver metastasis, lung cancer, renal cancer, prostate cancer as well as colon/rectum cancer) treatment with CyberKnife, SBRT and interventional radiology.
Safe and Effective Stereotactic Body Radiation Therapy (SBRT) for High-Risk Prostate Cancer Patients: 4-year Outcomes of a Phase II Trial
Hear about the outcomes from a novel, extreme hypofractionated approach (SBRT) to prostate cancer treatment using TomoTherapy®
Image-Guided Robotic Radiosurgery for Trigeminal Neuralgia
Frameless, non-isocentric irradiation of an extended segment of the trigeminal nerve introduces new concepts in stereotactic radiosurgery for medically resistant trigeminal neuralgia (TN).
The Outcome of the First 100 Nasopharyngeal Cancer Patients in Thailand Treated by Helical TomoTherapy®
Dr. Chitapanarux has completed her MD and postdoctoral studies in Radiation Oncology from Chiang Mai University. She is the associate professor and the Deputy Head of Department of Radiology, Faculty of Medicine, Chiang Mai University. She is also the Head of Chiang Mai Cancer Registry. She has published more than 50 papers in reputed journals.
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted Analysis
Jean-Emmanuel Bibault, M.D., MSc
Georges-Pompidou European Hospital, France
Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
To asses the potential dosimetric benefits associated with the CyberKnife (CK) tumor tracking capability, wherein an extra margin for respiratory tumor motion is not required, when compared to respiratory-gated volumetric-modulated arc therapy (VMAT) for hepatocellular carcinoma (HCC).
Once Daily Accelerated Partial Breast Irradiation: Preliminary Results with Helical TomoTherapy®
Accelerated partial breast irradiation (APBI) is becoming an option for patients with low-risk breast cancer. The current practice is 38.5 Gy in 10 fractions b.i.d. over 5 days. This fractionation has a higher bioequivalent dose compared to the standard schedule. We report on preliminary results of once-daily APBI in patients treated with TomoTherapy®.
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to the prostate while minimizing radiation to the adjacent critical organs. Large fraction sizes may increase urinary morbidity due to unavoidable treatment of the prostatic urethra. This study reports rates of acute urinary morbidity following SBRT for localized prostate cancer with prophylactic alpha-adrenergic antagonist utilization and urethral dose reduction (UDR).